How To Develop A Patient-First Strategy For CGT Commercialization
A patient centric approach to a complex treatment journey
Many new drug commercialization decisions need to happen early in the clinical development of a therapy, and cell and gene treatments are no different. As Amerisource Bergen’s Lung-I Cheng tells In Vivo, creating a patient-first blueprint is the best place to start.
